TELA Bio (TELA) Stock: Buy, Sell, or Hold?
TELA - TELA Bio, Inc. Common Stock
$1.18
0.09 (8.26%)
▲
5d:
+29.49%
30d:
+81.54%
90d:
+31.49%
WAIT
LOW Confidence
Analysis Updated: Sep 16, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When TELA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: TELA is 26.9% above its trading range ($0.93). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: TELA is 26.9% above its trading range ($0.93). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: TELA is currently trading at $1.18, which is considered extended relative to its 30-day fair value range of $0.64 to $0.93.
Technical Outlook: Technically, TELA is in a downtrend. The price is approaching resistance at $1.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.3% recently.
Market Sentiment: TELA scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.10 (+92.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TELA is in a downtrend. The price is approaching resistance at $1.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.3% recently.
Market Sentiment: TELA scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.10 (+92.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.64 -
$0.93
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price significantly overextended (+26.9% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.3%)
- BULLISH: Trading 92.7% below Wall St target ($2.10)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.64 -
$0.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.74
Resistance Level
$1.20
Current Trend
Downtrend
Technical data as of
Sep 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.37
Wall Street Target
$2.10
(+92.7%)
Revenue Growth (YoY)
-4.5%
Profit Margin
-51.5%
Share & Embed Analysis
Last updated: September 16, 2026 4:46 PM ET
Data refreshes hourly during market hours. Next update: 5:46 PM
Data refreshes hourly during market hours. Next update: 5:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TELA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$376 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 44 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 47 HOLD |
